Neuroendocrine Tumor – LabCorp – Camurus

People with gastroenteropancreatic neuroendocrine tumors are asked to participate in a research study being conducted by White Plains Hospital.

You may be eligible to participate in this study if you:

Inclusion Criteria for the Trial
• Are a male or female at least 18 years of age
• Have histologically confirmed, advanced (unresectable and/or metastatic), and well differentiated NET of GEP or presumed GEP origin
• Have at least 1 measurable, somatostatin receptor-positive*, lesion
Inclusion Criteria for the Open-label Extension Treatment Period
• Have At least 6 months of treatment with IMP
• Have disease progression confirmed by the BIRC

You may NOT participate in this study if you:

Exclusion Criteria for the Trial
• Have received investigational treatment in another clinical study within the past 4 weeks
• Have history of another primary malignancy
• Have had major surgery/surgical therapy for any cause within 1 month before screening
• Have patients with poorly controlled diabetes
• Have cardiac history or current diagnosis of cardiac disease
• Have Long QT syndrome
• Have known immunodeficiency virus (HIV) infection
• Are pregnant or breastfeeding
Exclusion Criteria for Open-label Extension Treatment Period
• Have unresolved, drug-related SAE
• Have clinically significant symptoms, medical conditions, rapid clinical deterioration, or other circumstances
• Are pregnant

Contact Information
Kasia Zarychta, Study Coordinator
41 E Post Road White Plains, NY 10601
Phone: (914) 849-7429